Companies

LIGAND PHARMACEUTICALS INC (LGND) SEC filings

CIK 0000886163 · Pharmaceutical Preparations (SIC 2834) · Nasdaq, OTC, OTC, OTC, OTC · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)268.1 M196.2 M
Net income (USD)-3.0 M629.3 M
Diluted EPS (USD/shares)6.13-1.98

Latest filings

FiledFormDescriptionPeriod
2026-10-064FORM 42026-10-02
2026-09-244PRIMARY DOCUMENT2026-09-22
2026-09-248-K8-K items 7.01,8.012026-09-24
2026-09-228-K8-K items 7.01,9.012026-09-22
2026-09-144PRIMARY DOCUMENT2026-09-10
2026-09-10144144
2026-09-084PRIMARY DOCUMENT2026-09-03
2026-09-03144144
2026-09-028-K/A8-K/A items 9.012026-07-14
2026-08-144PRIMARY DOCUMENT2026-08-12
2026-08-144PRIMARY DOCUMENT2026-08-12
2026-08-13SCHEDULE 13GSCHEDULE 13G
2026-08-12144144
2026-08-12144144
2026-08-0710-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-08-044PRIMARY DOCUMENT2026-08-03
2026-07-22S-8S-8
2026-07-148-K8-K items 1.01,2.01,2.03,7.01,9.012026-07-14
2026-07-064PRIMARY DOCUMENT2026-06-30
2026-07-064PRIMARY DOCUMENT2026-06-30
2026-07-064PRIMARY DOCUMENT2026-06-30
2026-07-01144144
2026-06-258-K8-K items 1.01,2.03,3.02,8.01,9.012026-06-25
2026-06-228-K8-K items 1.01,8.01,9.012026-06-22

Forms on file (last 1,000): 4 477, 8-K 187, 144 62, SC 13G/A 58, 10-Q 35, DEFA14A 19, CT ORDER 17, SC 13G 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=LGND (0.002 USD), /gw/filings/filings?ticker=LGND&form=8-K, /gw/filings/facts?ticker=LGND&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange